Contrast Agents Used in CECT Torso

1. Intravenous (IV) Iodinated Contrast - Primary Agent

A. Non-ionic Low-Osmolar Contrast Media (LOCM) - Most Widely Used

B. Non-ionic Iso-Osmolar Contrast Media (IOCM)

C. Ionic High-Osmolar Contrast Media (HOCM) - Largely Obsolete

• Diatrizoate (Hypaque, Gastrografin) - still used orally/rectally
• Iothalamic acid (Conray)
• These are mostly replaced by non-ionic agents due to higher reaction rates

2. Oral Contrast Agents (for bowel opacification)

3. Rectal Contrast

• Dilute iodinated solution (e.g., diatrizoate) given rectally for colorectal/pelvic studies
• Water-soluble agents preferred (not barium) to avoid spillage issues

4. Special / Niche Agents

• Lipiodol (ethiodized oil): Iodinated poppy seed oil; used for CT hepatic arteriography (CTHA), lymphangiography, and HCC detection
• Oral cholecystographic agents (e.g., meglumine iotroxate): rarely used now for biliary imaging

Key Points on Selection

• Non-ionic LOCM (like iohexol, iopamidol) are the standard for IV use - lower rates of adverse reactions compared to ionic HOCM
• Iodixanol (Visipaque) is preferred when renal protection is a concern (iso-osmolar, less nephrotoxic)
• For patients with contrast allergy history, premedication (steroids + antihistamine) is used; consider switching agent class
• For thyroid cancer follow-up, iodinated contrast should be avoided before radioiodine scans (iodine load blocks uptake) - as noted in Harrison's Principles of Internal Medicine 22E referencing the ACR Manual on Contrast Media (2023)

You Likely Mean One of These:

Most Likely Candidates:

1. Omnipaque (Iohexol) - GE Healthcare

• Non-ionic, low-osmolar (LOCM)
• Most widely used CT contrast worldwide
• Available in concentrations: 140, 180, 240, 300, 350 mgI/mL
• Used IV for CECT of torso, angiography, myelography, urography
• Also used orally for bowel opacification

2. Ultravist (Iopromide) - Bayer

• Non-ionic, low-osmolar (LOCM)
• Common in Europe and Asia
• Concentrations: 150, 240, 300, 370 mgI/mL
• Used for CECT, angiography, cardiac CT

3. Omniscan (Gadodiamide) - GE Healthcare

• This is an MRI contrast (gadolinium-based), NOT for CT
• Non-ionic, linear gadolinium agent
• Used for CNS and body MRI

Quick Comparison of the Main Non-ionic CT Agents:

Why Ultravist (Iopromide) is Used/Preferred for CECT Torso

1. Highest Available Iodine Concentration - 370 mgI/mL

• Ultravist 370 delivers the highest iodine concentration among commonly used agents
• Higher iodine concentration = better tissue and vascular enhancement per mL injected
• For torso imaging (liver, pancreas, aorta, portal vein), strong enhancement is critical for lesion detection
• You can achieve adequate enhancement with a smaller volume of contrast

2. Low Osmolality (Non-ionic LOCM)

• Osmolality ~774 mOsm/kg at 370 mgI/mL - well below ionic HOCM agents (~1400-2400 mOsm/kg)
• Low osmolality means:
  • Less pain/burning on injection
  • Lower risk of contrast-induced nephropathy (CIN)
  • Less endothelial disruption
  • Fewer cardiovascular effects (less vasodilatation, hypotension)

3. Low Viscosity - Enables Fast Injection Rates

• Viscosity of Ultravist 370 = 10 mPa·s at 37°C
• Lower viscosity (especially when warmed to body temperature) allows injection rates of 4-5 mL/sec through standard IV cannulas
• Fast injection rates are essential for CECT torso - you need a compact bolus to capture:
  • Arterial phase (20-35 sec delay)
  • Portal venous phase (60-70 sec delay)
  • Delayed/equilibrium phase (3-5 min)
• A poorly timed or slow bolus ruins phase separation

4. Non-ionic Monomer - Safety Profile

• As a non-ionic agent, it does not dissociate in solution - no free ions that interact with proteins/enzymes
• Results in: fewer anaphylactoid reactions, less cardiac toxicity, less neurotoxicity
• Radiopaedia's LOCM overview confirms iopromide is among the preferred non-ionic monomers for intravascular use

5. Broad FDA-Approved Indications

• Approved for: CT of head and body, excretory urography, cardiac angiography, peripheral angiography, visceral angiography, aortography, contrast mammography
• This versatility means one agent serves all CT torso needs - chest, abdomen, pelvis

6. Ready-to-Use, Stable Formulation

• Available in 300 and 370 mgI/mL concentrations in vials up to 500 mL bulk packs
• Stable, sterile, pyrogen-free - no preparation required
• Large bulk packaging suits high-volume CT departments

Comparison: Ultravist 370 vs Other Common Agents

• Visipaque (iodixanol) is iso-osmolar and better for renal protection, but has lower iodine concentration and higher viscosity
• Isovue 370 matches Ultravist's iodine concentration with slightly lower viscosity - equally good
• The choice between Ultravist, Omnipaque, and Isovue often comes down to institutional preference, cost, and supply contracts rather than clear clinical superiority

Bottom Line